D.J. Boote

419 total citations
7 papers, 319 citations indexed

About

D.J. Boote is a scholar working on Molecular Biology, Surgery and Otorhinolaryngology. According to data from OpenAlex, D.J. Boote has authored 7 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Otorhinolaryngology. Recurrent topics in D.J. Boote's work include Cancer therapeutics and mechanisms (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Head and Neck Cancer Studies (2 papers). D.J. Boote is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Neuroendocrine Tumor Research Advances (2 papers) and Head and Neck Cancer Studies (2 papers). D.J. Boote collaborates with scholars based in United Kingdom and Belgium. D.J. Boote's co-authors include N M Bleehen, David Poller, Michael H. Cummings, Michael Perry, Richard J. Osborne, P R Twentyman, C. LABURTE, J F Smyth, Ian F. Dennis and S. Falk and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Oral and Maxillofacial Surgery.

In The Last Decade

D.J. Boote

7 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D.J. Boote United Kingdom	5	162	113	91	73	66	7	319
C.S. Kwon United States	10	38 0.2×	36 0.3×	78 0.9×	57 0.8×	90 1.4×	21	360
Abbie L. Esterman United States	10	38 0.2×	36 0.3×	99 1.1×	120 1.6×	140 2.1×	16	388
P Lutz France	8	75 0.5×	30 0.3×	63 0.7×	43 0.6×	101 1.5×	19	336
Marita Prohn United States	9	125 0.8×	12 0.1×	54 0.6×	16 0.2×	45 0.7×	16	311
T.-U. Hausamen Germany	10	112 0.7×	17 0.2×	85 0.9×	16 0.2×	83 1.3×	30	306
Keya Basu India	10	39 0.2×	32 0.3×	87 1.0×	10 0.1×	70 1.1×	52	296
Ratna Paul Finland	9	50 0.3×	45 0.4×	46 0.5×	14 0.2×	34 0.5×	26	330
C. Tyler Kirkland United States	4	108 0.7×	10 0.1×	22 0.2×	34 0.5×	85 1.3×	6	292
N Blanc-Brunat France	11	48 0.3×	40 0.4×	172 1.9×	13 0.2×	30 0.5×	31	357
Ciara Kennedy United States	8	191 1.2×	10 0.1×	228 2.5×	37 0.5×	26 0.4×	13	402

Countries citing papers authored by D.J. Boote

Since Specialization

Citations

This map shows the geographic impact of D.J. Boote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.J. Boote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.J. Boote more than expected).

Fields of papers citing papers by D.J. Boote

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.J. Boote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.J. Boote. The network helps show where D.J. Boote may publish in the future.

Co-authorship network of co-authors of D.J. Boote

This figure shows the co-authorship network connecting the top 25 collaborators of D.J. Boote. A scholar is included among the top collaborators of D.J. Boote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.J. Boote. D.J. Boote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Vermorken, Jan B., et al.. (2007). Cost-effectiveness analysis of the EORTC 24971 (TAX 323) trial comparing docetaxel plus cisplatin and 5-fluorouracil versus standard treatment (cisplatin and 5-fluorouracil) as induction chemotherapy followed by radiation therapy in locally advanced unresectable squamous cell carcinoma of the head and neck (SCCHN). Journal of Clinical Oncology. 25(18_suppl). 6090–6090. 1 indexed citations

2.

Brennan, Peter A., N Mackenzie, Madan Ethunandan, et al.. (2005). Recurrent nodal metastases in the posterior triangle: Implications for treatment of the atypical tumour. British Journal of Oral and Maxillofacial Surgery. 44(2). 83–86. 2 indexed citations

3.

Downie, Ian, et al.. (2004). Does administration of isosorbide mononitrate affect cellular proliferation in oral squamous cell carcinoma? A prospective randomized clinical study. Journal of Oral and Maxillofacial Surgery. 62(9). 1064–1068. 8 indexed citations

4.

Poller, David, et al.. (2000). Fine-needle aspiration of the thyroid. Cancer. 90(4). 239–244. 117 indexed citations

5.

Ford, James M., et al.. (1997). A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma. Clinical Oncology. 9(1). 20–24. 34 indexed citations

6.

Boote, D.J., Ian F. Dennis, P R Twentyman, et al.. (1996). Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer.. Journal of Clinical Oncology. 14(2). 610–618. 150 indexed citations

7.

Falk, S., Tim Maughan, Alan Lamont, et al.. (1993). Phase II study of carboplatin and adriamycin as second line chemotherapy in small cell lung cancer. Clinical Oncology. 5(2). 85–88. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact